WASHINGTON – Representatives from the Consumer Healthcare Products Association (CHPA), Sanofi Consumer Healthcare, Haleon, Kenvue, and Bayer participated in a discussion this week hosted by U.S. Rep. Bob Latta (OH-05) to provide an analysis of the over-the-counter (OTC) Monograph Drug User Fee Program (OMUFA), how some OTCs come to market through the Rx-to-OTC-switch process, how
BOSTON – Yellow Wood Partners’ portfolio company Suave Brands Co. has signed a binding offer to acquire the ChapStick brand from Haleon. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of
The industry will soon come together to recognize the National Association of Chain Drug Stores for its myriad contributions to retailing and health care over the past nine decades. Scott Emerson, founder and CEO of the Emerson Group, and Lisa Paley, president of Haleon’s North American business, talk about plans for the event and how
Walgreens is staking a large claim in the burgeoning retail media business. In this week’s Video Forum, Robert Tompkins, the drug chain’s group vice president and general merchandise manager for health and wellness, and Katie Vogt, senior director of client success at Walgreens Advertising Group, exchange insights about retail media’s growing impact on the self-care
WARREN, N.J. — The shared values of Haleon and Target Corp. have led to the launch of their second annual All for Wellness campaign advancing equitable health care. The 360° omnichannel initiative educates shoppers on disparities in the system, while delivering care to underserved communities through a partnership with the nonprofit Remote Area Medical (RAM).
In the conclusion of a two-part interview, Haleon CEO Brian McNamara and Lisa Paley, president of the O-T-C supplier’s North American business, discuss the self-care category’s standing in a post-COVID world. Among the issues addressed are the continued importance of Rx-to-O-T-C switches, steps that the company is taking to fuel innovation, and the need for
This week’s Video Forum features two leaders of the newly minted Haleon. Brian McNamara, CEO of the company formerly known as GlaxoSmithKline Consumer Healthcare, and Lisa Paley, president of the business in North America, talks about how the nonprescription drug supplier intends to live up to its purpose of delivering better everyday health with humanity.
WARREN, N.J. — Consumer health leader Haleon commissions first-of-its-kind global study on health inclusivity, revealing the need for U.S. business, government, and health care providers to partner for greater health equity. First global benchmark for measuring countries’ health inclusivity places U.S. outside of the top 10 (ranks 11th) Partnership from all stakeholders involved in the U.S.
WARREN, N.J. — Haleon was launched earlier this year as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver better everyday health with humanity. The new company recently rolled out one of its first product launches with Theraflu Flu Relief
WARREN, N.J. — Haleon has been launched as an independent consumer health company following its spin-off from GSK. Trading of shares in the newly listed business began July 18 on the London Stock Exchange, where CEO Brian McNamara presided over the day’s ceremonial opening. Trading on the New York Stock Exchange is set to begin
LONDON — Haleon will be the name of the new company resulting from the proposed spin-off of GlaxoSmithKline plc’s (GSK) Consumer Healthcare business in mid-2022. Haleon (pronounced “Hay-Lee-On”) merges “hale,” an old English word that means “in good health,” and the Greek “leon,” which is associated with strength. The new brand identity was developed with